Released Sep 15, 2014, after the close
10-Q filed Sep 15, 2014, 46 days after period end · 0001354488-14-004649
Q3 2014 · 10-Q
Revenue—
Net Income$597.06K$597.06K −52.1% vs Q3 2013+82.2% vs Q2 2014
EPS Diluted$0.03$0.03 −52.8% vs Q3 2013+78.6% vs Q2 2014
Gross Profit$2,178,236−26.9%
Operating Income$698,260−54.5%
Operating Cash Flow$1,095,684+58.6%
Free Cash Flowderived$989,476+60.9%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | $597.06K | $1.25M | $1.28M | $1.50M |
| EPS Diluted | $0.03 | $0.05 | $0.06 | $0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR